FOSTER-CHEEK KAYE I exercised options at AGIOS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/23/2026ACC: 0001439222-26-000103
Director
Since May 2019
+17.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
20.69K acquired · 2.82K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
+2.82K
Price / share
—
Trade value
—
% of position
37.7%
6/18/2026
7.47K→10.28K
Total
Net shares
+2.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 6/18/2026 | M · Option Exercise | +2.82K | — | — | 37.7% | 7.47K | 10.28K |
| Total | +2.82K | $0.00 | ||||||
Derivative Transactions3
Restricted stock units
Direct
Converts to
Common stock
2.82K shares
Shares
−2.82K
Strike price
Held after
0.00
Exercisable
—
6/18/2026
Restricted stock units
Direct
Converts to
Common stock
2.93K shares
Shares
+2.93K
Strike price
Held after
2.93K
Exercisable
—
6/18/2026
Stock options (right to buy)
Direct
Converts to
Common stock
14.95K shares
Shares
+14.95K
Strike price
34.16
Held after
14.95K
Exercisable
—
6/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted stock units Direct | Common stock2.82K shares | 6/18/2026 | M · Option Exercise | −2.82K | — | 0.00 | |
| Restricted stock units Direct | Common stock2.93K shares | 6/18/2026 | A · Award | +2.93K | — | 2.93K | |
| Stock options (right to buy) Direct | Common stock14.95K shares | 6/18/2026 | A · Award | +14.95K | 34.16 | — | 14.95K |
Non-Derivative Holdings (Post-Transaction)1
Common stock
IndirectShares owned2.20K
Total
2.20K indirect2.20K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common stock | 2.20K | Indirect |
| Total | 2.20K | 2.20K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported